Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis | Zendy

Shiro Yokohama | Zendy; Yoshihiko Tokusashi | Zendy; Kimihide Nakamura | Zendy; Yosui Tamaki | Zendy; Satoshi Okamoto | Zendy; Mituyoshi Okada | Zendy; Kazunobu Aso | Zendy; Takenao Hasegawa | Zendy; Masaru Aoshima | Zendy; Naoyuki Miyokawa | Zendy; Masakazu Haneda | Zendy; Masashi Yoneda | Zendy

Open Access

Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis

Author(s) -

Shiro Yokohama,

Yoshihiko Tokusashi,

Kimihide Nakamura,

Yosui Tamaki,

Satoshi Okamoto,

Mituyoshi Okada,

Kazunobu Aso,

Takenao Hasegawa,

Masaru Aoshima,

Naoyuki Miyokawa,

Masakazu Haneda,

Masashi Yoneda

Publication year - 2006

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.v12.i2.322

Subject(s) - steatohepatitis , losartan , hepatic stellate cell , angiotensin ii , medicine , antagonist , fatty liver , endocrinology , angiotensin ii receptor antagonist , receptor , biology , disease

To investigate the efficacy of angiotensin II receptor antagonist on hepatic stellate cells (HSCs) activation in the patients with non-alcoholic steatohepatitis (NASH).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research